Showing results (201-210 of 1,617) with videos related to
Sort By:
Pageof 162
Clinical and Experimental Rheumatology|May 1, 1989
Use of high-dose intravenous immunoglobulin in systemic lupus erythematosus: report of three casesA Corvetta, R Della Bitta, A Gabrielli, et al.Der Anaesthesist|June 2, 2016
[A Germany-wide survey on anaesthesia in thoracic surgery]J Defosse, M Schieren, A Böhmer, et al.Frontiers in Molecular Biosciences|August 1, 2025
Development of a human colorectal carcinoma cell-based platform for studying inducible nitric oxide synthase expression and nitric oxide signaling dynamicsXi Chen, Elizabeth A Grimm, Yong QinToxics|February 26, 2026
Aggregate Consumer Exposure and Risk Assessment in the EU-A Case StudyJan Oltmanns, Christoph Scheibelein, Fabian A GrimmInternational Journal of Cancer|September 29, 2011
The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: its impact on the chemokine expression profile, including suppression of CXCL10Keiji Tanese, Elizabeth A Grimm, Suhendan EkmekciogluHuman Vaccines & Immunotherapeutics|January 26, 2017
Targeting iNOS to increase efficacy of immunotherapiesSuhendan Ekmekcioglu, Elizabeth A Grimm, Jason RoszikEchocardiography (Mount Kisco, N.Y.)|November 7, 2008
Quick resolution of takotsubo cardiomyopathy: a brief reviewSanjay Kumar, Nelson Mostow, Richard A GrimmScandinavian Journal of Immunology|October 1, 1983
An extended C1q-binding assay using lactoperoxidase- and chloramine-T-iodinated C1q. Immediate distinction between immune-aggregate-mediated and non-immune-aggregate-mediated C1q bindingP J Spaeth, A Corvetta, U E Nydegger, et al.Hepatology (Baltimore, Md.)|March 26, 2016
Assessing the therapeutic potential of lab-made hepatocytesMilad Rezvani, Andrew A Grimm, Holger WillenbringZentralblatt Fur Chirurgie|April 1, 2006
[Optimizing vacuum therapy in extensively undermined wounds]A Grimm, B Loos, R E HorchPageof 162